Corporate leadership depends on having clear targets. Under the Trump administration, leadership has shifted to aiming for ...

Building internal tools to benchmark energy footprints of cloud usage has become critical to deliver energy savings and ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma ...

The World Economic Forum currently places Australia 24th among 146 countries, down from 15th in 2006. At the current rate of ...

VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...

Tenet's large debt balance creates an ongoing servicing need that could be exacerbated by a large contraction in operating profitability. In such a scenario, Tenet may have trouble refinancing at ...

The newly released Insights Report, “Improvement in Safety Culture Linked to Better Patient and Staff Outcomes,” highlights ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Once it’s released, the Cradle-to-Career data system could reshape parents’ and students’ decisions and lead to significant ...